Arcus Biosciences market cap RCUS

Share price times shares outstanding: what the whole company sells for, since 2018.

Arcus Biosciences is worth $2.4B at the close on Oct 23, 2026, at $18.54 a share.

That is up 28% over the last year and down 1% over five years.

Its highest close in our data was $3.9B in Jun 2026.

Market cap over time

Year	End of year	Low	High	Change
2026 so far	$2.4B	$2B	$3.9B	−5%
2025	$2.5B	$727.1M	$2.8B	+78%
2024	$1.4B	$1.1B	$1.8B	−2%
2023	$1.4B	$1B	$1.7B	−5%
2022	$1.5B	$1.4B	$2.6B	−47%
2021	$2.8B	$1.6B	$3.3B	+69%
2020	$1.7B	$402.6M	$2.1B	+245%
2019	$488.4M	$295.3M	$570.9M	+2%
2018	$476.5M	$437M	$753.5M	n/a

Companies in Drug Manufacturers - General nearest Arcus Biosciences' size, closest first, today.

Company	Market cap
RCUSArcus Biosciences	$2.4B
PBHPrestige Consumer Healthcare	$2.3B
HRMYHarmony Biosciences	$2.1B
NRIXNurix Therapeutics	$2.8B
ANIPANI Pharmaceuticals	$1.7B
PAHCPhibro Animal Health	$1.6B
OGNOrganon	$3.6B
LQDALiquidia	$3.8B
ANABAnaptysbio	$1.5B
PCRXPacira BioSciences	$1.5B
ARQTArcutis Biotherapeutics	$3.9B
Peer median	$2.2B